{
    "code": "01036335",
    "url": "http:\/\/www.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=01036335",
    "time": "2016-11-18 13:30:09",
    "許可證字號": "衛署藥製字第036335號",
    "註銷狀態": "已註銷",
    "註銷日期": "99\/02\/08",
    "註銷理由": "屆期未申請展延",
    "有效日期": "92\/04\/27",
    "發證日期": "82\/04\/27",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHY00103633503",
    "中文品名": "倍司特克注射劑０．５公克（西勉諾欣）",
    "英文品名": "BESTCALL INTRAVENOUS FOR INJECTION 0.5G (CEFMENOXIME)",
    "適應症": "葡萄球菌、鏈球菌、肺炎雙球菌、腦膜炎球菌、及其他具有感受性細菌引起之感染症。",
    "劑型": "240乾粉注射劑",
    "包裝": "小瓶 盒裝",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "05限由醫師使用",
    "主成分略述": [
        "CEFMENOXIMEHEMIHYDROCHLORIDE"
    ],
    "限制項目": "01國　產 09委託製造",
    "申請商名稱": "1406701200  臺灣武田藥品工業股份有限公司",
    "主製造廠": {
        "主製造廠": "",
        "製造廠名稱": "0705330300  杏輝藥品工業股份有限公司",
        "製造廠廠址": "宜蘭縣冬山鄉中山村中山路８４號",
        "製造廠公司地址": "",
        "": ""
    },
    "CCC號列": "30042000319 人用醫藥製劑，含頭孢子菌類抗生素者Medicaments, containing cephalosporins, for human use",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "0812602610",
            "成分名稱": "CEFMENOXIME HEMIHYDROCHLORIDE",
            "含量描述": "0.5",
            "含量": "0.5000000000",
            "單位": "GM"
        }
    ]
}